After thoroughly evaluating the diagnostic efficacy of the four genes, we assessed the potential of PLVAP as a blood-based biomarker for disease diagnosis in blood samples of DKD and DKD-HCC. This evidence concerns the gene PLVAP and hepatocellular carcinoma.